ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Overview of EU and U.S. PV Regulations and PV Regulation Trend after China Joined ICH--China
October 12, 2018In China, people often equate PV with adverse drug reaction (ADR) monitoring, but in fact, PV is not simply ADR monitoring; it is a gradual outward expanding process with ADR monitoring at its core. -
Overview of EU and U.S. PV Regulations and PV Regulation Trend after China Joined ICH--U.S.
September 28, 2018In early September 2018, the National Medical Products Administration of China (NMPA) consecutively released announcements on revision of package inserts of four (varieties of) pharmaceutical products.
Pharma Sources Insight January 2025
